review Open AccessTop 1% cited

Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?

Environmental Health Perspectives · 2012 · Vol. 120(9) · pp. 1221–1229

Alistair B.A. Boxall✉(University of York)Murray A. Rudd(University of York)Bryan W. Brooks(Baylor University)Daniel J. Caldwell(Johnson & Johnson (United States))Kyungho Choi(Seoul National University)Silke Hickmann(German Environment Agency)Elizabeth Innes(Health Canada)Kim Ostapyk(Health Canada)Jane Staveley(Exponent (United States))Tim Verslycke(Gradient (United States))Gerald T. Ankley(Environmental Protection Agency)Karen Beazley(Dalhousie University)Scott E. Belanger(Procter & Gamble (United States))Jason P. Berninger‌(Baylor University)Pedro Carriquiriborde(Universidad Nacional de La Plata)Anja Coors(ECT Oekotoxikologie (Germany))Paul C. DeLeo(Deutsches Historisches Institut Washington)Scott D. Dyer(Procter & Gamble (United States))Jon F. Ericson(Pfizer (United States))François Gagné(Environment and Climate Change Canada)John P. Giesy(University of Saskatchewan)Todd Gouin(Unilever (United Kingdom))Lars Hällström(University of Alberta)Maja Karlsson(University of York)D. G. Joakim Larsson(University of Gothenburg)James M. Lazorchak(Environmental Protection Agency)Frank Mastrocco(Pfizer (United States))Alison McLaughlin(Health Canada)Mark E. McMaster(Environment and Climate Change Canada)Roger D. Meyerhoff(Eli Lilly (United States))Roberta Moore(Health Canada)Joanne L. Parrott(Environment and Climate Change Canada)Jason Snape(AstraZeneca (United Kingdom))Richard Murray‐Smith(AstraZeneca (United Kingdom))Mark R. Servos(University of Waterloo)Paul K. Sibley(University of Guelph)Jürg Oliver Straub(Roche (Switzerland))Nora D. Szabo(University of Ottawa)Edward Topp(Agriculture and Agri-Food Canada)Gerald R. Tetreault(University of Waterloo)Vance L. Trudeau(University of Ottawa)Glen Van Der Kraak(University of Guelph)

View via DOI Publisher page

Abstract

A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.

Pharmaceutical and Antibiotic Environmental Impacts Pesticide and Herbicide Environmental Studies Environmental Toxicology and EcotoxicologyPrioritizationGovernment (linguistics)Work (physics)BusinessEnvironmental planningEnvironmental resource managementEnvironmental scienceEngineeringProcess management

MeSH terms

Drug Resistance, MicrobialPharmaceutical PreparationsEnvironmental ExposureEnvironmental MonitoringHousehold ProductsHumansResearchRisk AssessmentDrug-Related Side Effects and Adverse Reactions

Citations

1,324

FWCI

44.22

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Pharmaceuticals in the environment—Global occurrences and perspectives